---
$id: https://graph.org.ai/products/commodity/51151607
$type: Product
source: UNSPSC
code: "51151607"
title: "Clidinium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clidinium

**UNSPSC Code**: 51151607
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C22H26NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BO76JF850N, chemically known as 1-azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl- but generally known as clidinium, which bears US NIH Compound Identifier 2784. European Medicines Agency schedules Clidinium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13391MIG. CLIDINIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CLIDINIUM remains the US FDA Preferred Term for this commodity. Clidinium bears US NLM identifiers UMLS ID C0055877 and NCI Concept Code C73138. SMILES: O(C1C2CC[N](C1)(CC2)C)C(=O)C(O)(C1CCCCC1)C1CCCCC1.

